tsc2

Showing 1 - 3 of 3

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

PEComa, Malignant, TSC1, TSC2 Trial (ABI-009)

Approved for marketing
  • PEComa, Malignant
  • +3 more
  • (no location specified)
Mar 2, 2022

TSC1, TSC2, Tuberous Sclerosis Complex Trial in Boston, New York (Everolimus)

Completed
  • TSC1
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 14, 2020